Brokerages Set Exact Sciences Co. (NASDAQ:EXAS) Price Target at $96.11

Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month target […]

Related Keywords

Chicago ,Illinois ,United States ,Everett Cunningham ,Sarah Condella ,William Blair ,Piper Sandler ,Sanfordc Bernstein ,Edmonds Duncan Registered Investment Advisors ,Kestra Advisory Services ,Hedge Funds Weigh In On Exact Sciences ,Sciences Co ,Sciences Stock ,News Ratings For Exact Sciences Daily ,Securities Exchange Commission ,Wolfe Research ,Sciences Company Profile ,Analyst Recommendations For Exact Sciences ,Harbour Investments Inc ,Segall Bryant Hamill ,Nasdaq ,Sciences Corporation ,Exact Sciences ,Get Free Report ,Exchange Commission ,Duncan Registered Investment Advisors ,Advisory Services ,Harbour Investments ,Get Free ,Recurrence Score Test ,Score Test ,Oncoextra Test ,Exact Sciences Daily ,Nasdaq Exas ,Texas ,Medical ,30063p10 ,Ratings ,Consensus ,